A group photo [Photo/sinopharm.com] 

China National Medical Device Co Ltd (CMDC), a subsidiary of China National Pharmaceutical Group Co Ltd (Sinopharm), signed an agreement with General Electric HealthCare China (GE Healthcare China) on Feb 24 in Beijing. The two parties announced the establishment of a joint venture in China on the research, development and manufacturing of high-end medical imaging equipment. CMDC will hold the majority stake. 

Xu gives a speech. [Photo/sinopharm.com] 

Xu Jinghe, deputy director of the National Medical Products Administration, said that the signing of the agreement holds great significance and emphasized the importance of strengthening quality management systems, enhancing risk control and ensuring product quality. 

Liu gives a speech. [Photo/sinopharm.com] 

Liu Jingzhen, chairman of Sinopharm, emphasized the importance of medical equipment as a foundation for healthcare and the well-being of the people. He said that the collaboration promotes innovative cooperation between State-owned enterprises and leading companies. Liu said that Sinopharm would continue to promote the integration of internal and external resources, build platforms, provide vital support for the healthcare industry and improve people’s health.

Zodl delivers a speech. [Photo/sinopharm.com] 

Helmut Zodl, vice-president and chief financial officer of GE Healthcare, said that GE Healthcare and Sinopharm have engaged in close cooperation over the past 30 years since the establishment of GE Hangwei Medical Systems Co Ltd (GE Hangwei) in China. He said he believes that the newly established joint venture could leverage the professional expertise and strong capabilities of the two parties. He said that GE Healthcare looks forward to continuing its collaboration with Sinopharm to bring better healthcare services to the Chinese people.

Yu delivers a speech. [Photo/sinopharm.com] 

Yu Qingming, chairman of Sinopharm Group Co Ltd, said that through this joint venture project, CMDC would engage in R&D and manufacturing cooperation with GE Healthcare China. He said he hopes that both sides would accelerate the implementation of the project. He said that product registration, market launch and effective production will rapidly enhance the safety, effectiveness and quality of domestically produced medical imaging equipment.

Zhang delivers a speech. [Photo/sinopharm.com] 

Zhang Yihao, president and CEO of GE Healthcare China, said that GE Hangwei, now a benchmark enterprise, is the crystallization of the first-time collaboration between GE Healthcare and Sinopharm. He said that the new collaboration represented another leap forward in GE Healthcare’s localization strategy. He said he hopes that the new company would focus on the urgent needs of grassroots healthcare and provide more targeted and economic medical devices to enable more people to enjoy high-quality medical services.

Li delivers a speech. [Photo/sinopharm.com] 

Li Yang, general manager of CMDC, said that the company would enhance its R&D on high-end medical devices, integrate resources from various enterprises and contribute to the development of the industrial chain. He said he believes that Sinopharm’s medical device research and manufacturing system would make new progress with support from all sides, contributing to the development of China's medical device industry. 

A group photo [Photo/sinopharm.com]